Search
for
Sort by
Research 61–90 of 187
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: A single-center retrospective study
- Evidence-Based Data on How Long to Treat to Achieve Treatment Response With Baricitinib in Severe Alopecia Areata
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Estimation of health utility values for alopecia areata
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- Alopecia universalis. Partial response to tofacitinib
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Alopecia Universalis Hair Regrowth with Hormones
- Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
- Systemic treatments for alopecia areata: A systematic review
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib